Yeqian Lai
Meizhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Pan-immune inflammation value and system inflammation response index associated with prolonged hospital stay of thyroid nodule patients undergoing ultrasound-guided microwave ablation, both aged ≤55 years and > 55 years.
Journal: Frontiers in endocrinology
Published: January 13, 2026
Exploring the role of EBV ZEBRA antibody levels in papillary thyroid cancer risk and drug resistance.
Journal: Discover oncology
Published: February 13, 2025
Positive preoperative circulating tumor cells level associated with lymph node metastasis in papillary thyroid carcinoma patients with capsular invasion.
Journal: World journal of surgical oncology
Published: December 26, 2024
Causal associations between circulating protein ratios and drug resistance in papillary thyroid cancer: a Mendelian randomization study.
Journal: Discover oncology
Published: November 20, 2024
Pretreatment level of circulating tumor cells is associated with lymph node metastasis in papillary thyroid carcinoma patients with ≤ 55 years old.
Journal: World journal of surgical oncology
Published: November 17, 2024
Preoperative circulating tumor cells level is associated with lymph node metastasis in patients with unifocal papillary thyroid carcinoma.
Journal: World journal of surgical oncology
Published: November 12, 2024
Unraveling the role of gut microbiota and immune cells in thyroid cancer and tumor drug resistance.
Journal: Discover oncology
Published: August 28, 2024
Preoperative High Level of Circulating Tumor Cells is an Independent Risk Factor for Central Lymph Node Metastasis in Papillary Thyroid Carcinoma with Maximum Lesion Diameter ≤1.0 cm.
Journal: International journal of general medicine
Published: July 21, 2024
Risk factors analysis of lateral cervical lymph node metastasis in papillary thyroid carcinoma: a retrospective study of 830 patients.
Journal: World journal of surgical oncology
Published: March 20, 2024
The Association of Pretreatment Systemic Immune Inflammatory Response Index (SII) and Neutrophil-to-Lymphocyte Ratio (NLR) with Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma.
Journal: International journal of general medicine
Published: January 27, 2024
Thyroglobulin Antibody (TgAb) Positive is an Independent Risk Factor for Lymph Node Metastasis in Patients with Differentiated Thyroid Carcinoma.
Journal: International journal of general medicine
Published: September 12, 2023
Younger Than 55 Years Old and BRAF V600E Mutation are Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinomas ≤1.0 cm but Not in >1.0 cm.
Journal: International journal of general medicine
Published: February 28, 2023
Showing 1-12 of 12
Last Updated: 09/26/2026